Stanford’s AI-Designed Phages: Why This Matters Researchers at Stanford University and the Arc Institute used Evo 2 (a generative AI model for DNA design) to create complete bacteriophage genomes. Starting from ΦX174, they synthesised nearly […]
From Immunophysiology to Immunotherapy Ilya Pharma evolved from the internationally recognized research conducted by the laboratories of the co-founders Mia Phillipson, Professor of Physiology at Uppsala University, Sweden, and Stefan Roos, Professor at the Swedish […]
Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, today announced securing $60 million in funding, a clinical update for its pivotal Phase 3 RESTORATiVE303 study of VE303 for the […]
From Immunophysiology to Immunotherapy Ilya Pharma evolved from the internationally recognized research conducted by the laboratories of the co-founders Mia Phillipson, Professor of Physiology at Uppsala University, Sweden, and Stefan Roos, Professor at the Swedish […]
Two new studies jointly published in Nature: The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases — and may […]
As oral drug delivery moves beyond the small intestine, ileocolonic targeting is emerging as a key enabler for next‑generation therapeutics. This article explores how colonic delivery technologies – including pH‑dependent polymers, multi‑trigger coatings and ready‑to‑fill […]
Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for […]
The global probiotics market has experienced sustained and rapid growth over the past decade, driven by increasing consumer awareness of gut health, immunity, and the central role of the microbiome in overall well‑being. Discussions at […]
Gut microbiome research has changed. Many studies no longer stop at identifying which microbes are present. They are now also looking at what those microbes are doing, often by measuring the metabolites they produce or […]
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that all primary and secondary objectives were met in its advanced melanoma (MELODY-1) Phase 1b trial. […]
Kanvas Biosciences, a full-stack spatial biology company, today announced it has raised a $48 million Series A funding round co-led by existing investors DCVC and Lions Capital LLC. Additional participating investors include Gates Foundation, ATHOS […]